 		   MRI contrast developer Pharmacyclics of Sunnyvale, CA, has signed a contract manufacturing agreementwith Burroughs Wellcome for production of the company's Gadoliteagent. Pharmacyclics is developing Gadolite for enhancement ofMRI scans of the abdomen and pelvis. The agent last month completedphase-three clinical trials and Pharmacyclics plans to submita new drug application in the middle of this year.

MRI contrast developer Pharmacyclics of Sunnyvale, CA, has signed a contract manufacturing agreementwith Burroughs Wellcome for production of the company's Gadoliteagent. Pharmacyclics is developing Gadolite for enhancement ofMRI scans of the abdomen and

Pharmacyclics inks manufacturing deal